Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gardner

Showing results (561-570 of 569) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 569 results.
JAMA|September 1, 2004
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trialJames A de Lemos, Michael A Blazing, Stephen D Wiviott, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathologySaba Nayar, Joana Campos, Charlotte G Smith, et al.
Journal of the American College of Cardiology|June 17, 1998
Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary ThrombosisJ S Mandak, J C Blankenship, L H Gardner, et al.
Annals of the Rheumatic Diseases|November 26, 2018
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndromeSaba Nayar, Joana Campos, Charlotte G Smith, et al.
JAMA|July 9, 2004
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trialMichael A Blazing, James A de Lemos, Harvey D White, et al.
Communications Biology|May 4, 2022
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interactionSaba Nayar, Elena Pontarini, Joana Campos, et al.
ACS Chemical Biology|September 4, 2020
Unraveling the Mechanism of a LOV Domain Optogenetic Sensor: A Glutamine Lever Induces Unfolding of the Jα HelixJames N Iuliano, Jinnette Tolentino Collado, Agnieszka A Gil, et al.
Nature Communications|January 3, 2025
Molecular and spatial analysis of tertiary lymphoid structures in Sjogren's syndromeSaba Nayar, Jason D Turner, Saba Asam, et al.
Nature|September 6, 2016
Targeting renal cell carcinoma with a HIF-2 antagonistWenfang Chen, Haley Hill, Alana Christie, et al.
Pageof 57

Showing results (561-570 of 569) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 569 results.
JAMA|September 1, 2004
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trialJames A de Lemos, Michael A Blazing, Stephen D Wiviott, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathologySaba Nayar, Joana Campos, Charlotte G Smith, et al.
Journal of the American College of Cardiology|June 17, 1998
Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary ThrombosisJ S Mandak, J C Blankenship, L H Gardner, et al.
Annals of the Rheumatic Diseases|November 26, 2018
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndromeSaba Nayar, Joana Campos, Charlotte G Smith, et al.
JAMA|July 9, 2004
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trialMichael A Blazing, James A de Lemos, Harvey D White, et al.
Communications Biology|May 4, 2022
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interactionSaba Nayar, Elena Pontarini, Joana Campos, et al.
ACS Chemical Biology|September 4, 2020
Unraveling the Mechanism of a LOV Domain Optogenetic Sensor: A Glutamine Lever Induces Unfolding of the Jα HelixJames N Iuliano, Jinnette Tolentino Collado, Agnieszka A Gil, et al.
Nature Communications|January 3, 2025
Molecular and spatial analysis of tertiary lymphoid structures in Sjogren's syndromeSaba Nayar, Jason D Turner, Saba Asam, et al.
Nature|September 6, 2016
Targeting renal cell carcinoma with a HIF-2 antagonistWenfang Chen, Haley Hill, Alana Christie, et al.
Pageof 57